Maarten Postma | Chair, Faculty of Economics & Business,
University of Groningen

Maarten Postma, Chair, Faculty of Economics & Business,, University of Groningen

Prof Maarten J Postma (29/01/1960) holds the chair Global Health Economics at the University Medical Center Groningen (UMCG) and the faculty of Economics & Business, both at the University of Groningen and is director of UMCG’s research institute SHARE, bringing various university faculties together. Also, he is Prof in Pharmacoeconomics at the Departments of Pharmacy at the University of Groningen, Pharmacology at the Airlangga University (Surabaya, Indonesia) and Pharmaceutical Care Innovation at Universitas Padjadjaran (Bandung, Indonesia).
He did his MSc in econometrics and his PhD in health economics. He specifically leads a team of 100 staff, PhD and post-doc researchers in health- and pharmacoeconomics, contributing to many international research networks and scientific communications. He is specialized in the role of pharmacoeconomics/health economics in the reimbursement process. He serves (served) on various committees advising the Dutch government on reimbursement of drugs and vaccines. Also, he is advisor to various health-economics consultancy companies and pharmaceutical companies worldwide, Ministries of Health in neighbouring countries, member of editorial boards of scientific journals (a.o. Value in Health), on advisory boards for pharmaceutical companies and expert consultant for WHO. He is a member of UK’s Joint Committee of Vaccination & Immunization since 2014.

Appearances:



Day 2 - Wednesday 15th October @ 09:00

Valuing Vaccines Beyond Cost-Effectiveness

  • How can we evolve beyond traditional metrics to capture the full societal value of vaccines - from pandemic prevention to economic stability?
  • What would a new multidimensional framework for measuring vaccine impact look like, and how could it transform funding priorities?
  • How do we bridge the gap between theoretical frameworks and real-world policy adoption - what are the barriers and opportunities?
  • As the world faces new health challenges, how can expanded valuation metrics help drive better decision-making in vaccine development and implementation?
last published: 28/May/25 12:25 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK

 

Wing-Yun Cheung
Wing-Yun.Cheung@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.